JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M310373200 on November 3, 2003

J. Biol. Chem., Vol. 279, Issue 7, 5802-5810, February 13, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/7/5802    most recent
M310373200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gottifredi, V.
Right arrow Articles by Prives, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gottifredi, V.
Right arrow Articles by Prives, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Decreased p21 Levels Are Required for Efficient Restart of DNA Synthesis after S Phase Block*

Vanesa Gottifredi{ddagger}, Kristine McKinney§, Masha V. Poyurovsky§, and Carol Prives¶

From the Department of Biological Sciences, Columbia University, New York, New York 10027

The cyclin-dependent kinase inhibitor p21, a major transcriptional target of the tumor suppressor p53, plays a critical role in cell cycle arrest in G1 and G2 after DNA damage. It was previously shown that in some human cell lines when S phase is arrested, p53 is transcriptionally impaired such that some p53 targets including p21 are only weakly induced. We show here that during S phase arrest proteasome-mediated turnover of p21 is significantly increased in a manner that is independent of p53. It is well established that p21 can interact both with cyclin-dependent kinase complexes and with proliferating cell nuclear antigen (PCNA). Interestingly, the scant amount of p21 detected during S phase block cannot fully saturate cyclin A-cyclin-dependent kinase 2 complexes and does not interact detectably with PCNA. Importantly, DNA elongation assays in isolated nuclei show that the C terminus of p21 containing the PCNA-binding domain effectively blocks this process. This implies that p21 down-regulation could be an essential requirement for efficient restart of DNA synthesis. In line with this, only cells expressing low levels of p21 immediately progress through the cell cycle upon release from S phase arrest, whereas the remaining few high p21 producing cells move much more slowly through S. Thus, p21 down-regulation is multiply determined and is required for the reversibility of the arrest in S phase.


Received for publication, September 18, 2003 , and in revised form, October 22, 2003.

* This work was supported by a special fellowship from the Leukemia and Lymphoma Society (to V. G.) and by National Institutes of Health Grant CA58316 (to C. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} Present address: Instituto de Investigaciones Bioquímicas Fundación Campomar, Buenos Aires 1405, Argentina.

§ These authors contributed equally to this work.

To whom correspondence should be addressed. E-mail: clp3{at}columbia.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Q. Kan, S. Jinno, K. Kobayashi, H. Yamamoto, and H. Okayama
Cdc6 Determines Utilization of p21WAF1/CIP1-dependent Damage Checkpoint in S Phase Cells
J. Biol. Chem., June 27, 2008; 283(26): 17864 - 17872.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. A. Levesque, A. A. Fanous, A. Poh, and A. Eastman
Defective p53 signaling in p53 wild-type tumors attenuates p21waf1 induction and cyclin B repression rendering them sensitive to Chk1 inhibitors that abrogate DNA damage-induced S and G2 arrest
Mol. Cancer Ther., February 1, 2008; 7(2): 252 - 262.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Mattia, V. Gottifredi, K. McKinney, and C. Prives
p53-Dependent p21 mRNA Elongation Is Impaired when DNA Replication Is Stalled
Mol. Cell. Biol., February 15, 2007; 27(4): 1309 - 1320.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
P. Perucca, O. Cazzalini, O. Mortusewicz, D. Necchi, M. Savio, T. Nardo, L. A. Stivala, H. Leonhardt, M. C. Cardoso, and E. Prosperi
Spatiotemporal dynamics of p21CDKN1A protein recruitment to DNA-damage sites and interaction with proliferating cell nuclear antigen
J. Cell Sci., April 15, 2006; 119(8): 1517 - 1527.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. L. Maude and G. H. Enders
Cdk Inhibition in Human Cells Compromises Chk1 Function and Activates a DNA Damage Response
Cancer Res., February 1, 2005; 65(3): 780 - 786.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.